205 related articles for article (PubMed ID: 34537326)
1. Therapeutic potential of iron modulating drugs in a mouse model of multiple system atrophy.
Shukla JJ; Stefanova N; Bush AI; McColl G; Finkelstein DI; McAllum EJ
Neurobiol Dis; 2021 Nov; 159():105509. PubMed ID: 34537326
[TBL] [Abstract][Full Text] [Related]
2. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.
Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of FABP7 by MF 6 counteracts cerebellum dysfunction in an experimental multiple system atrophy mouse model.
Cheng A; Jia W; Finkelstein DI; Stefanova N; Wang H; Sasaki T; Kawahata I; Fukunaga K
Acta Pharmacol Sin; 2024 Jan; 45(1):66-75. PubMed ID: 37605049
[TBL] [Abstract][Full Text] [Related]
4. Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications.
Kaindlstorfer C; Sommer P; Georgievska B; Mather RJ; Kugler AR; Poewe W; Wenning GK; Stefanova N
Neurotox Res; 2015 Oct; 28(3):185-94. PubMed ID: 26194617
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
[TBL] [Abstract][Full Text] [Related]
6. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
[TBL] [Abstract][Full Text] [Related]
7. Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation.
Cheng A; Kawahata I; Wang Y; Jia W; Wang H; Sekimori T; Chen Y; Suzuki H; Takeda A; Stefanova N; Finkelstein DI; Ma W; Chen M; Sasaki T; Fukunaga K
Brain; 2023 Aug; 146(8):3172-3180. PubMed ID: 37082980
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy.
Sturm E; Fellner L; Krismer F; Poewe W; Wenning GK; Stefanova N
Neurotherapeutics; 2016 Oct; 13(4):871-879. PubMed ID: 27259295
[TBL] [Abstract][Full Text] [Related]
9. [Multiple system atrophy with a-/hypo-ceruloplasminemia: distribution of iron in brains of 2 autopsy cases].
Kurisaki H; Yomono H; Murayama S; Hebisawa A
Rinsho Shinkeigaku; 2002 Apr; 42(4):293-8. PubMed ID: 12561083
[TBL] [Abstract][Full Text] [Related]
10. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.
Ubhi K; Rockenstein E; Mante M; Inglis C; Adame A; Patrick C; Whitney K; Masliah E
J Neurosci; 2010 May; 30(18):6236-46. PubMed ID: 20445049
[TBL] [Abstract][Full Text] [Related]
11. The molecular tweezer CLR01 reduces aggregated, pathologic, and seeding-competent α-synuclein in experimental multiple system atrophy.
Herrera-Vaquero M; Bouquio D; Kallab M; Biggs K; Nair G; Ochoa J; Heras-Garvin A; Heid C; Hadrovic I; Poewe W; Wenning GK; Klärner FG; Schrader T; Bitan G; Stefanova N
Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165513. PubMed ID: 31319154
[TBL] [Abstract][Full Text] [Related]
12. ATH434 Reduces α-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System Atrophy.
Heras-Garvin A; Refolo V; Schmidt C; Malfertheiner K; Wenning GK; Bradbury M; Stamler D; Stefanova N
Mov Disord; 2021 Nov; 36(11):2605-2614. PubMed ID: 34236731
[TBL] [Abstract][Full Text] [Related]
13. Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathies.
Hass EW; Sorrentino ZA; Xia Y; Lloyd GM; Trojanowski JQ; Prokop S; Giasson BI
Acta Neuropathol Commun; 2021 Aug; 9(1):146. PubMed ID: 34454615
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and exendin-4 treatment for multiple system atrophy.
Bassil F; Canron MH; Vital A; Bezard E; Li Y; Greig NH; Gulyani S; Kapogiannis D; Fernagut PO; Meissner WG
Brain; 2017 May; 140(5):1420-1436. PubMed ID: 28334990
[TBL] [Abstract][Full Text] [Related]
15. Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy.
Visanji NP; Collingwood JF; Finnegan ME; Tandon A; House E; Hazrati LN
J Parkinsons Dis; 2013; 3(4):523-37. PubMed ID: 24113558
[TBL] [Abstract][Full Text] [Related]
16. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein transgenic mice: relevance to multiple system atrophy.
Fillon G; Kahle PJ
Mov Disord; 2005 Aug; 20 Suppl 12():S64-6. PubMed ID: 16092093
[TBL] [Abstract][Full Text] [Related]
18. A novel mouse model for investigating α-synuclein aggregates in oligodendrocytes: implications for the glial cytoplasmic inclusions in multiple system atrophy.
Ishimoto T; Oono M; Kaji S; Ayaki T; Nishida K; Funakawa I; Maki T; Matsuzawa SI; Takahashi R; Yamakado H
Mol Brain; 2024 May; 17(1):28. PubMed ID: 38790036
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy.
Venezia S; Refolo V; Polissidis A; Stefanis L; Wenning GK; Stefanova N
Mol Neurodegener; 2017 Jul; 12(1):52. PubMed ID: 28676095
[TBL] [Abstract][Full Text] [Related]
20. Cellular iron deposition patterns predict clinical subtypes of multiple system atrophy.
Lee S; Martinez-Valbuena I; Lang AE; Kovacs GG
Neurobiol Dis; 2024 Jul; 197():106535. PubMed ID: 38761956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
